NDC 83047-0300-30

Obecabtagene autoleucel infusion (CAR-T cell therapy) at Temple University Hospital, Inc.- Main Campus

AI-generated description

How this description was generated

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

INV - OBECABTAGENE AUTOLEUCEL INTRAVENOUS SUSPENSION 300 X 10EXP6 CELL (IRB# EA25-1017)

Philadelphia, PA

See all hospitals reporting NDC 83047-0300-30 →

Pricing by billing methodology

Price type

How this price compares nationally

Temple University Hospital, Inc.- Main Campus’s median price of $726.2k is 22% above the median hospital's median price ($594.6k), higher than 69% of the 13 hospitals reporting NDC 83047-0300-30. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Apr 13, 2026

Compare to other hospitals

See Obecabtagene autoleucel infusion (CAR-T cell therapy) pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.